- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05363176
Treatment, Pain, and Opioids
Telehealth CBT to Increase Engagement in Pain Treatment Among Veterans Using Prescription Opioids
Background: Chronic pain and negative consequences of long-term opioid therapy are related public health concerns associated with significant functional impairment, high psychiatric comorbidity, and premature mortality, particularly among Veterans. Clinical Practice Guidelines for opioid prescribing and pain management recommend using non-pharmacological approaches as first-line treatments. Psychosocial interventions (e.g., cognitive-behavioral therapy) have strong evidence supporting their ability to improve pain outcomes. Patient beliefs about the stigma associated with psychological interventions, opioid analgesics, ability of psychosocial intervention to improve pain among others can greatly interfere with the patients' ability to initiate and maintain engagement in psychosocial interventions and other non-pharmacological approaches.
Significance/Impact: Without a concerted effort at affecting beliefs that impede engagement in treatment, Veterans who may benefit from the treatment, will not receive it. This can result in continued risk for negative consequences associated with long-term opioid therapy and inadequate pain management. Cognitive-Behavioral Therapy for Treatment Seeking (CBT-TS) is an evidence-based intervention that directly intervenes on beliefs that act as barriers to treatment initiation and retention. By intervening on these beliefs, this study has the potential to improve engagement in psychosocial pain interventions and other non-pharmacological pain treatments, which will improve pain-related interference and functioning and reduce reliance on opioid analgesics. This study addresses VHA/VA Veteran care priorities including opioid use, pain management, and access and directly addresses priorities of the HSR&D Targeted Solicitation for Service Directed Research on Opioid Safety and Opioid Use Disorder.
Innovation: The proposed study is the first application of CBT-TS for Veterans with chronic pain who are receiving opioid analgesics-a notably high-risk, treatment-resistant population. This is the first study to directly intervene on thoughts about psychosocial interventions.
Specific Aims: The specific aims are to: test the effects of CBT-TS to increase initiation of psychosocial interventions for pain among Veterans receiving opioid analgesics for chronic pain (Aim 1), test the effects of CBT-TS to increase the retention in psychosocial interventions for pain among Veterans receiving opioid analgesics for chronic pain (Aim 2), and evaluate the effects of CBT-TS in improving pain and substance use outcomes among Veterans receiving opioid analgesics for chronic pain (Aim 3). The investigators will also test the effects of CBT-TS on the initiation of and retention to other non-pharmacological pain treatments (Exploratory Aim).
Methodology: Participants (N = 300) will be randomized to either the CBT-TS condition or an education control condition. Participants in both conditions will complete assessments on pain, treatment engagement, and opioid use at baseline, and 1-, 3-, and 6-months post-treatment to assess primary, secondary, and exploratory outcomes.
Implementation/Next Steps: Results from this study will provide critical information on increasing engagement of psychosocial interventions for pain, which can be used to inform future implementation and dissemination efforts. The research team will work with the VHA National Pain Management and Opioid Safety office and the VHA Office of Patient Centered Care & Cultural Transformation to identify implementation and dissemination efforts. CBT-TS is undergoing current implementation research to increase mental health functioning and this effort could be expanded to also increase treatment engagement of psychosocial interventions for pain and other non-pharmacological pain treatments.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
New York
-
Canandaigua, New York, United States, 14424-1159
- VA Finger Lakes Healthcare System, Canandaigua, NY
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants will include English-speaking Veterans on long-term opioid therapy prescribed opioid analgesics (>20mg morphine equivalent daily [MEDD] and at least a 90 days supply).
Participants must report pain that occurs on at least half the days for six months.
- They must score at least a 4 on each item of the three items on a brief pain intensity and interference measure.
Exclusion Criteria:
- Veterans will be excluded if they are currently undergoing oncology treatment, are hospice patients, and have a recent or upcoming surgery.
- Veterans will be excluded if they are currently engaged (i.e., within the past month) in non-pharmacological pain treatment.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CBT for Treatment Seeking
CBT delivered over the course of 1, ~45 minute session delivered via telehealth.
|
CBT delivered over the course of 1, ~45 minute sessions delivered via telehealth.
Other Names:
|
Active Comparator: Pain Treatment Education
Pain treatment education is delivered over the course of 1, ~45 minute session delivered via telehealth
|
Pain treatment education describes a variety of pain treatments offered in the VA.
It is delivered over the course of 1, ~45 minute session delivered via telehealth
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Medical Record Review and Treatment Utilization Form
Time Frame: Baseline to 6-months post-treatment
|
This will capture treatment initiation and treatment retention information including treatment types, dates of service, number of sessions, and type and dose of VHA and non-VHA medications dispensed.
|
Baseline to 6-months post-treatment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pain Treatment Willingness Scale (PTWS)
Time Frame: Baseline to 6-months post-treatment
|
Beliefs about psychosocial and other non-pharmacological pain treatments will be assessed using a modified PTWS.
The scale consists of seven items assessing respondents' willingness to use opioids or non-pharmacological approaches using a 6-point rating scale.
(1 = "not at all willing" to 6 "extremely willing").
|
Baseline to 6-months post-treatment
|
Medication Beliefs Questionnaire
Time Frame: Baseline to 6-months post-treatment
|
The MBQ uses five items to assess beliefs about one's response to, relief from, and potential for addiction to opioid analgesics.
Respondents are asked to select one of five responses for each item (e.g., "None at all" to "Complete", "Much worse" to "Much better").
|
Baseline to 6-months post-treatment
|
Beck Hopelessness Scale (BHS)
Time Frame: Baseline to 6-months post-treatment
|
The BHS contains 20 true-false items designed to assess beliefs about the future.
Higher scores represents greater hopelessness.
|
Baseline to 6-months post-treatment
|
Pain Catastrophizing Scale
Time Frame: Baseline to 6-months post-treatment
|
The PCS is a 13-item measure, with each item rated on a 5-point rating scale (0 = "Not at all" to 4 = "All the time").
Higher scores represent more rumination, magnification, and helplessness over pain.
|
Baseline to 6-months post-treatment
|
Pain Self-Efficacy Questionnaire (PSEQ)
Time Frame: Baseline to 6-months post-treatment
|
The PSEQ is an 11-item measure that assesses one's confidence in performing activities while in pain.
|
Baseline to 6-months post-treatment
|
Tampa Scale for Kinesiophobia-11 (TSK-11)
Time Frame: Baseline to 6-months post-treatment
|
The TSK-11 is an 11-item measure assessing pain-related fear of movement or injury with higher scores representing greater fear of movement.
|
Baseline to 6-months post-treatment
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
PROMIS Profile-29
Time Frame: Baseline to 6-months post-treatment
|
The PROMIS-29 provides a profile of one's health-related quality of life with components including pain interference, physical functioning, sleep disturbance, social functioning, anxiety, fatigue, and depression.
|
Baseline to 6-months post-treatment
|
Opioid use
Time Frame: Baseline to 6-months post-treatment
|
A 17-item measure will be used that assesses the frequency of aberrant drug-related behaviors and other behaviors that are prevalent among pain patients who are using prescription opioids.
The rating scale ranges from 0 ("Never") to 4 ("Very Often"), with higher scores indicating greater risk.
|
Baseline to 6-months post-treatment
|
Collaborators and Investigators
Investigators
- Principal Investigator: Lisham Ashrafioun, PhD, VA Finger Lakes Healthcare System, Canandaigua, NY
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SDR 21-018
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Vastra Gotaland RegionCompletedPain, Chronic | Widespread Chronic PainSweden
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Societa Italiana Anestesia Analgesia Rianimazione...RecruitingPost Operative Pain | Postoperative Pain, Chronic | Post Surgical PainItaly
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
University Health Network, TorontoAcademic Medical Organization of Southwestern Ontario; York University; Toronto...Not yet recruitingPain, Acute | Pain, Chronic | Post-surgical Pain | Post-Surgical Pain, ChronicCanada
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
Clinical Trials on Cognitive-Behavioral Therapy for Treatment Seeking
-
University of RochesterCompletedDepression | Insomnia | Anxiety | Post Traumatic Stress Disorder | Alcohol Use Disorder | Mental Health IssueUnited States
-
Universidad Nacional Autonoma de MexicoIstituto Auxologico Italiano; Medica Sur Clinic & FoundationUnknown
-
Dartmouth-Hitchcock Medical CenterRecruitingInsomnia | Crohn DiseaseUnited States
-
Brigham and Women's HospitalRecruiting
-
VA Pittsburgh Healthcare SystemVA Office of Research and DevelopmentCompleted
-
Ohio State University Comprehensive Cancer CenterAmerican Cancer Society, Inc.; Lance Armstrong FoundationCompletedDepression | Pain | Leukemia | Fatigue | Multiple Myeloma | Insomnia | Pancreatic Cancer | Esophageal Cancer | Lung Cancer | Glioblastoma Multiforme | Sleep Disorders | Uncertainty | Ovarian Neoplasm | Anxiety Disorder | Psychological Intervention | Relapsed Lymphoma | Worry | Cognitive-behavioral Therapy | Stage III or IV Cervical... and other conditionsUnited States
-
Johns Hopkins UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedOsteoarthritis | Sleep Initiation and Maintenance DisordersUnited States
-
University of LouisvilleNational Institute of Mental Health (NIMH)Active, not recruiting
-
Tel Aviv UniversityCompleted
-
Harvard UniversityCompletedDepression | Anxiety